Table 1.
Incidence at 9–15 months Pten+/− | Incidence at 12–21 months Ptenhy/+ | |
---|---|---|
Mammary tumors | 85 | 60 |
Uterine tumors | 66 | 28 |
Lymphadenopathy | 100 | 40 |
Lung tumors | 0 | 28 |
Intestinal polyps | 66 | 28 |
Pheochromocytoma | 100 | 14 |
Tumor spectrum in the Ptenhy/+ and Pten+/− long-term survivor female mice (mice between 12–21 months of age for the Ptenhy/+ and 9–15 months of age for the Pten+/−). Data are shown in percentages.